Myhelix Inc. is a direct-to-consumer genetic testing company that focuses on helping individuals make healthier meal choices based on their DNA. Founded in 2017 by a team of biotechnology scientists and creative specialists, the company's mission is to educate people about their genetic predispositions regarding nutrition and empower them to customize their meal plans accordingly. Myhelix Inc. operates at the intersection of analytics, healthcare, and information technology and is headquartered in Ukraine. The company's innovative approach to utilizing genetic information for personalized nutrition aligns with the growing trend of precision health and wellness. By leveraging comprehensive digital formats, Myhelix Inc. aims to demystify genetics and make it accessible to the broader population. Currently, there is no public information available about Myhelix Inc.'s last investment or the participating investors. However, the potential for leveraging genetic data to revolutionize everyday health decisions positions Myhelix Inc. as a compelling player in the burgeoning field of personalized genetics. This unique positioning may attract interest from venture capital firms seeking to capitalize on the expanding intersection of genetics and consumer wellness.
There is no investment information
No recent news or press coverage available for Myhelix Inc..